Exploring new drugs from microbial natural products using advanced genetic techniques
Accessing and expanding microbial bioactive chemical diversity by synthetic biology and new enzymology
This study is all about finding new natural substances from tiny organisms that could help create better medicines, so patients like you might have access to new and improved treatments in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10842321 on NIH RePORTER |
What this research studies
This research focuses on discovering new bioactive compounds from microbes by utilizing advanced genetic and bioinformatics techniques. It aims to identify and produce novel natural products that could lead to new medications. By mining microbial genomes and employing synthetic biology, the researchers hope to enhance the production of these compounds, which are essential for drug development. Patients may benefit from new treatments derived from these discoveries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could be treated by novel drugs derived from microbial natural products.
Not a fit: Patients who do not have conditions that could be addressed by new microbial-derived medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new medications derived from previously inaccessible microbial compounds.
How similar studies have performed: Previous research has shown success in using synthetic biology for the production of bioactive compounds, indicating a promising approach in this field.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Ding, Yousong — University of Florida
- Study coordinator: Ding, Yousong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.